Pfizer Independent Medical Education Grant for Prostate Cancer (US)

Deadline: 28-Apr-2026

The Pfizer Independent Medical Education (IME) grant supports organizations in developing educational initiatives for healthcare professionals managing metastatic prostate cancer. The program focuses on targeted therapy integration, PARP inhibitor efficacy and safety, and guideline-aligned clinical decision-making. Funding ranges from $5,000 to $250,000 per project over 18 months.

Overview

The Pfizer IME Grant Program is designed to enhance the knowledge, skills, and clinical decision-making capabilities of healthcare teams treating patients with metastatic prostate cancer (mPCa). The initiative emphasizes:

• Improving guideline concordance and integration of diagnostic testing into clinical practice

• Understanding existing and emerging data on PARP inhibitors (PARPi)

• Educating on PARPi combinations and strategies to manage associated side effects

This grant encourages the creation of educational programs that bridge current knowledge gaps, support evidence-based care, and improve patient outcomes across diverse clinical settings.

Key Focus Areas

• Clinical Decision-Making: Support healthcare professionals in applying current guidelines for metastatic castration-sensitive and castration-resistant prostate cancer

• Targeted Therapies: Educate teams on the optimal use of PARP inhibitors, including combination strategies

• Side Effect Management: Equip healthcare providers with strategies to monitor and mitigate adverse events associated with targeted therapies

• Testing Integration: Encourage incorporation of molecular and genetic testing into routine practice to guide therapy selection

Funding Details

• Grant Amount: $5,000 – $250,000 per project

• Project Duration: Up to 18 months

• Eligible Costs: Program development, educational materials, faculty training, dissemination of educational content

Who Can Apply

Eligible applicants include:

• Healthcare professional schools (medical, dental, nursing, allied health, pharmacy)

• Healthcare institutions of any size

• Professional organizations and medical societies

• Medical education companies or entities focused on healthcare professional education
  Ineligible Applicants: Individuals, independent physician practices not affiliated with a hospital or academic institution

Collaboration Requirements

• Multi-departmental or multi-institutional collaborations are permitted

• The requesting organization must maintain leadership over the project

• All participating entities must have a relevant, defined role

• Project lead must be an employee or authorized contractor of the requesting organization

Accreditation & Compliance

• Organizations must be legally able to receive funding directly from Pfizer Inc.

• If providing continuing education credit, the applicant must hold appropriate accreditation

• Recommended to confirm institutional eligibility prior to submission

How to Apply

1. Identify a relevant educational gap in metastatic prostate cancer care

2. Design an evidence-based educational program aligned with Pfizer IME objectives

3. Define target audience, expected outcomes, and program impact

4. Ensure all collaborating entities and project lead meet eligibility criteria

5. Submit the application with required documentation, including institutional confirmation and accreditation details if applicable

Why It Matters

• Enhances clinical knowledge and skills for healthcare teams

• Supports patient-centered care and guideline-aligned practice

• Improves understanding of targeted therapy strategies in metastatic prostate cancer

• Promotes safe and effective management of side effects

FAQs

1. What types of organizations are eligible?
Medical, nursing, allied health, pharmacy schools, healthcare institutions, professional societies, or medical education companies focused on healthcare education.

2. Can independent physicians apply?
No, individuals or independent physician practices not affiliated with a hospital, academic institution, or society are not eligible.

3. What is the funding range?
$5,000 to $250,000 per project.

4. How long can a project last?
Up to 18 months.

5. Can multiple organizations collaborate on a project?
Yes, but the requesting organization must maintain a leadership role, and all partners must have a defined, relevant role.

6. Are continuing education credits required?
Not required, but if offered, the applicant must hold appropriate accreditation.

7. What are the main educational focus areas?
Guideline adherence, targeted therapy integration, PARPi efficacy and safety, combination strategies, side effect management, and testing integration.

Conclusion

The Pfizer Independent Medical Education Grant empowers organizations to design impactful educational initiatives that improve the care of patients with metastatic prostate cancer. By enhancing clinical knowledge and guideline implementation, the program strengthens healthcare teams’ ability to deliver optimal, evidence-based patient management.

For more information, visit Pfizer.